12 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jun 2041. from the record

Free plan: 3 watched companies. Pro: unlimited.

Alerts on its grants, lapses and transfers.

Ending by 2030

Jun 2041

Next term end

Patent families

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

2026202720282029203020312032203320342035203620372038203920402041 2042 204320442045

notable patents fee due within 90 days all others Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Notable

Pharmaceutical Composition Comprising 5-Methoxy-N,N-DIMETHYLTRYPTAMINE US 11,518,743

The most cited patent in this portfolio, cited by 8 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2041.

Ends Jun 2041 · High confidence Also notable

Composition Comprising a Benzoate Salt of 5-Methoxy-N,N-DIMETHYLTRYPTAMINE US 11,518,742

Cited by 6 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2041.

Ends Jun 2041 · High confidence Also notable

Ergoline Analogues US 11,697,651

Cited by 3 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2042.

Ends Jan 2042 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Dec 20, 2026
The maintenance fee for Pharmaceutical Composition Comprising 5-Methoxy-N,N-DIMETHYLTRYPTAMINE (US 11,680,044) comes due Dec 20, 2026. Unpaid by Jun 21, 2027, it lapses early.
1 fee due Jan 11, 2027
The maintenance fee for Ergoline Analogues (US 11,697,651) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
2 fees due Apr 3 to 17, 2027 · next Apr 3

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 5 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Ergoline Analogues	3 in force	to Jan 2042
5-Methoxy-N,N-DIMETHYLTRYPTAMINE (5-MeO-DMT) Formulations	2 in force	to Aug 2043
Pharmaceutically Acceptable Salts and Compositions Thereof	2 in force	to Sep 2042
Composition Comprising a Benzoate Salt of 5-Methoxy-N,N-DIMETHYLTRYPTAMINE	2 in force	to Jun 2041
Pharmaceutical Composition Comprising 5-Methoxy-N,N-DIMETHYLTRYPTAMINE	2 in force	to Jun 2041

Patents held now

Soonest term end first.

Patent	Title	Status	Expires	Confidence
US 11,518,742	Composition Comprising a Benzoate Salt of 5-Methoxy-N,N-DIMETHYLTRYPTAMINE In force Term ends Jun 14, 2041 · High confidence	In force	Term ends Jun 14, 2041	High confidence
US 11,518,743	Pharmaceutical Composition Comprising 5-Methoxy-N,N-DIMETHYLTRYPTAMINE In force Term ends Jun 14, 2041 · High confidence	In force	Term ends Jun 14, 2041	High confidence
US 11,603,353	Composition Comprising a Benzoate Salt of 5-Methoxy-N,N-DIMETHYLTRYPTAMINE In force Term ends Jun 14, 2041 · High confidence	In force	Term ends Jun 14, 2041	High confidence
US 11,680,044	Pharmaceutical Composition Comprising 5-Methoxy-N,N-DIMETHYLTRYPTAMINE In force Term ends Jun 14, 2041 · High confidence	In force	Term ends Jun 14, 2041	High confidence
US 11,697,651	Ergoline Analogues In force Term ends Jan 17, 2042 · High confidence	In force	Term ends Jan 17, 2042	High confidence
US 11,787,806	Ergoline Analogues In force Term ends Jan 17, 2042 · High confidence	In force	Term ends Jan 17, 2042	High confidence
US 12,275,735	Ergoline Analogues In force Term ends Jan 17, 2042 · High confidence	In force	Term ends Jan 17, 2042	High confidence
US 12,534,441	Tryptamine Analogues In force Term ends Jun 9, 2042 · High confidence	In force	Term ends Jun 9, 2042	High confidence
US 11,773,063	Pharmaceutically Acceptable Salts and Compositions Thereof In force Term ends Sep 9, 2042 · High confidence	In force	Term ends Sep 9, 2042	High confidence
US 12,264,131	Pharmaceutically Acceptable Salts and Compositions Thereof In force Term ends Sep 9, 2042 · High confidence	In force	Term ends Sep 9, 2042	High confidence

10 of 12 patents shown.

Pro members see all 12.

Pro members: see all 12 patents

Also on record, not counted in the 12: 13 applications pending · 3 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built

Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.

Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Beckley Psytech Limited